Stop by booth #420 to learn how the Aventa Lymphoma test can help resolve ambiguous lymphoma
diagnoses by evaluating all clinically relevant rearrangements in B- and T-cell lymphomas.

---

Join our Corporate Workshop

Aventa Lymphoma: Robust Genome Wide Fusion and Rearrangement Detection, a Modern Alternative to FISH for Diagnostic Testing

Date: Wednesday, November 12, 2025
Time: 1:00 PM - 1:50 PM
Location: 157AB, Level 1

Aventa Lymphoma is a clinically validated lab developed test that leverages Hi-C sequencing to detect all clinically relevant fusions and rearrangements in B- and T-cell lymphomas. This workshop will provide an overview of test technology as well as the clinical experience of three practicing pathologists who have utilized the test, including their results on comparison with clinical FISH, deconvolution of atypical FISH results, and clinical case studies.

---

Corporate Workshop Speaker(s)

Anthony Schmitt, PhD
SVP of Science
Arima Genomics

Matija Snuderl, MD (he/him/his)
Director of Molecular Pathology
NYU Langone Health

Ying S. Zou, MD, PhD, FACMG (she/her/hers)
Director of Cancer Genetic Laboratory
The Johns Hopkins University

Adam Smith, PhD, FCCMG, FACMG, erCLG  
Clinical Laboratory Director, Cytogenetics   
Center for Molecular Biology and Pathology  
Labcorp